RTWG Rtw Biotech Opportunities Ltd

TIDMRTW

RNS Number : 9402D

RTW Venture Fund Limited

27 June 2023

LEI: 549300Q7EXQQH6KF7Z84

27 June 2023

RTW VENTURE FUND LIMITED

(the "Company")

Change of Name

RTW Venture Fund , a London Stock Exchange-listed investment fund focused on identifying transformative assets with high growth potential across the life sciences sector is pleased to announce that the Company has changed its name to RTW Biotech Opportunities Ltd. The Guernsey registry has confirmed the name change, effective 22 June 2023.

Shareholdings will be unaffected by the change of name, and the Company's TDIMs, ISIN and SEDOLs all remain unchanged. Existing share certificates should be retained and will remain valid for all purposes.

Rod Wong, Managing Partner of RTW Investments, LP, the Company's Investment Manager commented:

"We are pleased to announce the change of the Company's name to RTW Biotech Opportunities Ltd which better places us among our listed healthcare and biotech investment company/trust peers and more accurately reflects the Company's full life cycle approach to biotech investing as a partner that can invest in both the private and public domains and across the capital structure."

For Further Information:

 
 RTW Investments, LP                                 +44 (0)20 7959 6361 
 Woody Stileman, Managing Director 
  Krisha McCune, Director, Client Service 
 
 Buchanan                                            +44 (0)20 7466 5107 
 Charles Ryland 
 Henry Wilson 
 George Beale 
 
 Numis                                               +44 (0)20 7260 1000 
 Freddie Barnfield 
 Nathan Brown 
 Euan Brown 
 
 BofA Securities                                     +44 (0) 20 7628 1000 
 Edward Peel 
 Kieran Millar 
 
 
  Cadarn Capital 
  David Harris                                         +44 (0) 73 6888 3211 
 
 
   Elysium Fund Management Limited                     +44 (0) 14 8181 0100 
 Joanna Duquemin Nicolle, Chief Executive Officer 
 Sadie Morrison, Managing Director 
 
 Morgan Stanley Fund Services USA LLC                +1 (914) 225 8885 
 

About RTW Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CANFLFVSRIIRFIV

(END) Dow Jones Newswires

June 27, 2023 02:00 ET (06:00 GMT)

Rtw Biotech Opportunities (LSE:RTWG)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Rtw Biotech Opportunities (LSE:RTWG)
Gráfica de Acción Histórica
De May 2023 a May 2024